Multiple Serotonin Receptors: Opportunities for New Treatments for Obesity?

10.1037/h0077040

10.1016/0014-2999(86)90405-X

10.1016/0024-3205(87)90418-8

Bjork L., 1991, Pharmacology of the novel 5‐hydroxytryptamine1A receptor antagonist (S)‐5‐fluoro‐8‐hydroxy‐2‐(dipropylamino)tetralin: inhibition of (R)‐8‐hydroxy‐2‐(dipropylamino)tetralin‐induced effects, J Pharmacol Exp Ther., 258, 58

Blundell JE., 1977, Is there a role for 5‐hydroxytryptamine in feeding, Int J Obes., 1, 15

10.1016/0028-3908(94)90059-0

Cliffe IA, 1993, The evolution of selective, silent 5‐HT1A antagonists, Curr Drugs Serotonin., 1, 1

10.1111/j.1476-5381.1978.tb07765.x

10.1016/0006-8993(93)90759-G

Dourish CT., 1992, Advances in the Biosciences, 179

Dourish CT., 1995, The Neuropharmacology of Appetite

10.1007/BF00443413

10.1007/BF00431709

10.1016/0361-9230(85)90005-X

10.1007/BF02412123

10.1016/0165-6147(86)90318-4

10.1016/S0195-6663(86)80058-7

10.1177/026988118700100106

10.1126/science.2781294

Drescher K., 1985, Neurochemical and behavioural effects after 5,7‐DHT lesion of the median and dorsal raphe nucleus, Biogenic Amines., 2, 227

10.1097/00001756-199211000-00019

10.1016/0006-8993(93)90973-Q

10.1016/0014-2999(93)90280-U

Fletcher A., 1994, A pharmacological profile of WAY 100635, a potent and selective 5‐HT1A receptor antagonist, Br J Pharmacol., 112, 91P

10.1016/0165-6147(93)90185-M

10.1016/0006-8993(91)90082-7

10.1007/BF00177567

10.1016/0006-8993(91)91241-R

10.1016/0006-8993(92)90953-7

10.1016/0006-8993(93)90635-Z

10.1016/0091-3057(93)90385-7

Fornal CA, 1994, Single‐unit recordings from freely‐moving animals provide evidence that WAY 100635 but not (S) WAY 100635, blocks the action of endogenous serotonin at the 5‐HT autoreceptor, Br J Pharmacol., 112, 92P

Fuller RW, 1981, Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m‐trifluoromethylphenylpiperazine, J Pharmacol Exp Ther., 218, 636

10.1016/S0195-6663(86)80050-2

10.1007/BF00187255

10.1016/0306-4530(88)90032-7

10.1016/0014-2999(88)90212-9

10.1007/BF02244895

10.1038/305140a0

Gurling J., 1994, Effects of acute and chronic treatment with the selective 5‐HT1A receptor antagonist WAY 100635 on hippocampal 5‐HT release in vivo, Br J Pharmacol., 112, 299P

Hartley JE, 1995, Evidence for the involvement of 5‐HT2C receptors in mediating fenfluramine‐induced anorexia in rats, Br J Pharmacol., 114, 373P

10.1016/0014-2999(94)90181-3

Hartley JE, 1994, The effects of WAY 100635, a potent and selective 5‐HT1A receptor antagonist on feeding and 8‐OH‐DPAT‐induced feeding in the rat, Br J Pharmacol., 112, 298P

Hartley JE, 1994, The effects of WAY 100635, the selective 5‐HT1Areceptor antagonist on feeding induced by buspirone, gepirone, ipsapirone and clonidine in the rat, Br J Pharmacol., 113, 125P

10.1523/JNEUROSCI.07-03-00894.1987

10.1016/0014-2999(88)90236-1

Hjorth S., 1987, Brain 5‐HT1A Receptors: Behavioral and Neurochemical Pharmacology, 94

10.1016/0024-3205(90)90097-B

Hoyer D., 1991, 5‐HT1A Agonists, 5‐HT3 Antagonists and Benzodiazepines. Their Comparative Behavioural Pharmacology, 31

10.1016/0165-6147(89)90159-4

10.1016/0014-2999(87)90435-3

Hutson PH, 1988, Infusion of the 5‐hydroxytryptamine agonists RU 24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia, Psychopharmacology., 97, 550

10.1016/0014-2999(88)90019-2

10.1016/0014-2999(86)90445-0

10.1016/0304-3940(89)90698-8

10.1111/j.1476-5381.1988.tb11508.x

10.1007/BF02431539

10.1111/j.1476-5381.1991.tb12369.x

10.1007/BF02431540

10.1016/0014-2999(87)90561-9

Kennett GA, 1995, Evidence of tolerance development to the hyperphagic but not anxiolytic‐like actions of SB 200646A, a 5‐HT2C/2B receptor antagonist, after chronic treatment, Br J Pharmacol.

10.1016/0014-2999(87)90336-0

10.1111/j.1476-5381.1994.tb14808.x

10.1016/0304-3940(89)90032-3

10.1007/BF02245211

Leibowitz SF., 1986, Brain monoamines and peptides: role in the control of eating behaviour, Fed Proc., 45, 1396

10.2165/00003495-199000393-00005

10.1021/jm00170a007

10.1016/0028-3908(94)90058-2

10.1016/0091-3057(87)90127-4

Meller E., 1990, Receptor reserve for 5‐hydroxytryptamine1A‐mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5‐hydroxytryptamine1A agonists, Mol Pharmacol., 37, 231

10.1007/BF00427333

Middlemiss DN., 1987, Brain 5‐HT1A Receptors: Behavioural and Neurochemical Pharmacology, 82

10.1016/0014-2999(83)90230-3

10.1007/BF01244460

10.1007/BF00445567

10.1007/BF00442252

10.1016/0014-2999(88)90818-7

Palacios JM, 1987, Brain 5‐HT1A Receptors: Behavioural and Neurochemical Pharmacology, 67

10.1016/0014-2999(84)90057-8

10.1016/0306-4522(87)90326-5

10.1016/0014-2999(93)90994-S

10.1016/0028-3908(94)90066-3

10.1016/0301-0082(86)90011-0

10.1016/0024-3205(77)90006-6

10.1016/0028-3908(89)90080-4

10.1007/BF00499059

10.1126/science.8091214

10.1016/0006-8993(83)90945-9

10.1007/BF00174687

10.1016/0922-4106(93)90150-8

10.1002/cne.902340306

10.1111/j.1476-5381.1993.tb13630.x

10.1016/0304-3940(91)90668-J

10.1016/0361-9230(90)90194-5

10.1177/026988119400800103

Steinbusch HWM., 1984, Handbook of Chemical Neuroanatomy, 68

10.1016/0163-7258(87)90057-X

10.1016/0014-2999(85)90099-8

Vickers SP, 1994, Analysis of the attentuation of d‐fenfluramine anorexia by metergoline but not WAY 100135, J Psychopharmacology., 8, A27

10.1007/BF02244883

10.1016/0091-3057(86)90116-4

Wilkinson LO, 1991, Serotonin Receptor Subtypes: Basic and Clinical Aspects, 147

10.1016/0014-2999(92)90586-S

Winsauer PJ, 1994, Effects of chlordiazepoxide, 8‐OH‐DPAT and ondansetron on radiation‐induced decreases in food intake in rats, J Pharmacol Exp Ther., 270, 142

10.1016/S0195-6663(86)80055-1

Wurtman RJ, 1984, Eating and Its Disorders, 77

10.1016/0014-2999(87)90241-X